In another cancer-related study, miR-145-5p inhibited tumor angiogenesis by targeting serpin family E member 1 (SERPINE1), a positive regulator for the VEGFR-2 signaling pathway (Teng et al., 2021). The gene discussed is SERPINE1; the disease is neoplasm.